These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30101563)

  • 1. Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies.
    Watson N; Wu K; Farr P; Reynolds NJ; Hampton PJ
    Br J Dermatol; 2019 Jan; 180(1):195-196. PubMed ID: 30101563
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
    Echeverría-García B; Nuño-González A; Dauden E; Vanaclocha F; Torrado R; Belinchón I; Pérez-Zafrilla B;
    Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection.
    Piaserico S; Conti A; Coati I; Galdo G; Bernabucci V; Zanca A; Drabeni M; Masutti F; Musumeci ML; Alberti A; Russo FP
    G Ital Dermatol Venereol; 2019 Jun; 154(3):376-377. PubMed ID: 28712266
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.
    Lund T; Thomsen SF
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28071837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Kimball AB; Guenther L; Kalia S; de Jong EMGJ; Lafferty KP; Chen DY; Langholff W; Shear NH
    JAMA Dermatol; 2021 Mar; 157(3):301-306. PubMed ID: 33533924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal.
    Al-Janabi A; Jabbar-Lopez ZK; Griffiths CEM; Yiu ZZN
    Br J Dermatol; 2019 Jun; 180(6):1348-1351. PubMed ID: 30632140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
    Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe psoriasis with ustekinumab during pregnancy.
    Andrulonis R; Ferris LK
    J Drugs Dermatol; 2012 Oct; 11(10):1240. PubMed ID: 23134993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
    Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
    Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab.
    Nakahara T; Konishi S; Yasukochi Y; Esaki H; Tsuji G; Kido-Nakahara M; Furue M
    J Dermatol; 2019 May; 46(5):e157-e158. PubMed ID: 30353917
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of systemic therapies in the treatment of psoriasis with concomitant cirrhosis: a retrospective study.
    Blaszczak AM; Dunaway S; Ali Alikhan M; Kelly S; Levin D; Kaffenberger J
    Int J Dermatol; 2019 Nov; 58(11):e228-e229. PubMed ID: 31334835
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
    Gordon KB; Strober B; Lebwohl M; Augustin M; Blauvelt A; Poulin Y; Papp KA; Sofen H; Puig L; Foley P; Ohtsuki M; Flack M; Geng Z; Gu Y; Valdes JM; Thompson EHZ; Bachelez H
    Lancet; 2018 Aug; 392(10148):650-661. PubMed ID: 30097359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.
    Galluzzo M; D'Adamio S; Bianchi L; Talamonti M
    J Dermatolog Treat; 2019 Feb; 30(1):40-44. PubMed ID: 29676599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics exposure during pregnancy and breastfeeding in a psoriasis patient.
    Mugheddu C; Atzori L; Lappi A; Murgia S; Rongioletti F
    Dermatol Ther; 2019 May; 32(3):e12895. PubMed ID: 30958637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials.
    McMichael A; Desai SR; Qureshi A; Rastogi S; Alexis AF
    Am J Clin Dermatol; 2019 Apr; 20(2):267-276. PubMed ID: 30471012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy during Ustekinumab Treatment for Severe Psoriasis.
    Rocha K; Piccinin MC; Kalache LF; Reichert-Faria A; Silva de Castro CC
    Dermatology; 2015; 231(2):103-4. PubMed ID: 25790947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
    Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
    Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.
    Langley RG; Tsai TF; Flavin S; Song M; Randazzo B; Wasfi Y; Jiang J; Li S; Puig L
    Br J Dermatol; 2018 Jan; 178(1):114-123. PubMed ID: 28635018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.